Abajar, Fe A.
HRN: 24-33-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/01/2024
02/07/2024
IVT
1.5g
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes